|
HPX
|
Hisamitsu Pharmaceutical Co. Inc
|
DE
|
F
|
|
HROW
|
Harrow Health, Inc.
|
US
|
NASDAQ
|
|
HRTIS
|
Herantis Pharma Oyj
|
FI
|
HE
|
|
HYPE3
|
Hypera S.A
|
BR
|
SA
|
|
HZNP
|
Horizon Pharma, Inc.
|
US
|
NASDAQ
|
|
IB3A
|
IONIC BRANDS CORP.
|
DE
|
F
|
|
IDT
|
IDT Australia Limited
|
AU
|
ASX
|
|
IGXT
|
Intelgenx Technologs
|
US
|
OTC
|
|
IMM
|
Immupharma Plc
|
UK
|
LSE
|
|
INAF
|
Indofarma Tbk
|
ID
|
JK
|
|
INDOCO
|
Indoco Remedies Limited
|
IN
|
NSE
|
|
INDV
|
Indivior Plc
|
UK
|
LSE
|
|
INLB
|
Item 9 Labs Corp
|
US
|
OTC
|
|
INVA
|
Innoviva, Inc.
|
US
|
NASDAQ
|
|
IPCIF
|
Intellipharmaceutics International Inc
|
US
|
OTC
|
|
IPN
|
Ipsen SA
|
FR
|
PA
|
|
IQ70
|
1CM INC.
|
DE
|
F
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
US
|
NASDAQ
|
|
ITRM
|
Iterum Therapeutics plc
|
US
|
NASDAQ
|
|
IVX
|
Invion Ltd
|
AU
|
ASX
|